Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members and maintain the reputation of the sector.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

Senior Manufacturing Manager

At Broken String Biosciences, we are driving innovation in genome editing technologies to enable safer, more effective cell and gene therapies. Our mission is to advance the next generation of precise, safe, and efficient therapies through our cutting-edge technology platforms.

Our flagship technology, INDUCE-seq™, offers rapid and accurate DNA break mapping, providing critical insights into how genome editors interact with DNA. This data-driven approach helps unlock new editing targets and supports the development of life-saving therapies that are safer by design.

Team Leader - Computational Chemistry

About Us:

Domainex is a multi-award winning integrated drug discovery CRO that has been setting the highest standards in drug discovery, with a particular emphasis on small molecule research, since 2001. We work in partnership with clients from a variety of sectors including academic, pharmaceutical, biotechnology and patient foundation organisations around the world.   Our vision is to be the pre-eminent partner for innovative drug discovery services that improve the quality of life for people living with disease.

Industrial Placement Student (Chemistry)

Domainex is a multi-award winning integrated drug discovery CRO that has been setting the highest standards in drug discovery, with a particular emphasis on small molecule research, since 2001. We work in partnership with clients from a variety of sectors including academic, pharmaceutical, biotechnology and patient foundation organisations around the world. Our vision is to be the pre-eminent partner for innovative drug discovery services that improve the quality of life for people living with disease.

Biotech Pioneers Leadership Summit (BPLS) 2024

Featuring a diverse lineup of international speakers, thought leaders and business leaders from within and beyond the industry to bring in new perspectives and insights.  A dynamic mix of talks, masterclasses, and panel discussions. 
9am to 5pm

*One Nucleus Members from biotech/pharma, including CROs/CDMOs, receive 20% off registration.

Please email [email protected] to request the discount code.

Roz Sutton Appointed as Senior Director of Regulatory Affairs at tranScrip

tranScrip is delighted to announce the appointment of Roz Sutton as Senior Director of Regulatory Affairs. Roz brings two decades of experience in Global Regulatory Affairs, having held leadership roles at top pharmaceutical companies including Roche and GSK, as well as in regulatory consultancy at DLRC. Her appointment underscores tranScrip’s commitment to strengthening its regulatory team as it continues to expand its expertise and service offerings.

Dr. Kathryn Owen Joins tranScrip as Executive Medical Director

We are delighted to announce that Dr. Kathryn (Kate) Owen has joined tranScrip as Executive Medical Director in our Early Development Group.

Kate brings with her 24 years of extensive experience as a consultant Pharmaceutical Physician, with a specialised focus in oncology and haemato-oncology. She has an exceptional track record in early clinical development, guiding projects from candidate drug selection through to phase IIb trials.

UK Budget an Opportunity for Government to Lay Out Clear ‘NHS Investment Strategy’

  • Government’s ambitions to solve NHS crisis lack sufficient detail.
  • Collaboration with private sector and life sciences is crucial to tackle NHS backlog and provide much needed investment.
  • Tax and fiscal incentives important to encourage investment in the sector.
  • Regulation and procurement barriers must be tackled if innovative solutions are to feed through to the NHS.

15 October 2024

Overcoming Pharmaceutical and Other Materials Issues Before They Exist. Two New Scientific Papers on the Conclusions of the 7th Crystal Structure Prediction Blind Test

Cambridge, UK – 16 October 2024 – The Cambridge Crystallographic Data Centre (CCDC) announces two significant scientific papers detailing the findings of the 7th Crystal Structure Prediction (CSP) Blind Test. To coincide with the publication of the two papers, the CCDC has released a CSP Blind Test database that contains 171,679 entries from 207 landscapes.

Expanding CSP Beyond Pharmaceuticals

Subscribe to